SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-165505
Filing Date
2018-05-17
Accepted
2018-05-16 18:16:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d586814ds3.htm S-3 405319
2 EX-1.2 d586814dex12.htm EX-1.2 160935
3 EX-5.1 d586814dex51.htm EX-5.1 37217
4 EX-23.2 d586814dex232.htm EX-23.2 1592
5 GRAPHIC g586814dsp001.jpg GRAPHIC 2365
6 GRAPHIC g586814g03k11.jpg GRAPHIC 46721
7 GRAPHIC g586814g25q87.jpg GRAPHIC 125114
  Complete submission text file 0001193125-18-165505.txt   846050
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-224989 | Film No.: 18841250
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1